Biology-First Drug Discovery
Founded in 2020 by UCSF scientists Dr. Yerem Yeghiazarians and Dr. Kurosh Ameri, Soley Therapeutics is a biology-first drug discovery company that uses cell stress sensing to identify first-in-class medicines. The company is building a pipeline spanning oncology, neurodegeneration, and metabolic diseases using proprietary imaging, automation, and AI/ML.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJan 2026
Dec 2025
Dec 2020
Create a free account to see which investors have funded this company.
Create Free Account
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
